Tag Archive for Stemtech

Stemtech Announces The Launch of StemPets

Stemtech Corporation (OTCQB;STEK), a leader in the development and distribution of stemceutical™ products for humans offered since 2005, is proud to announce an exciting new product line into the pet health care industry with the launch of “StemPets™.”
This revolutionary product is designed to provide substantial health benefits to dogs, cats, and other beloved pets, tapping into the $303 billion pet health care market.
Recognizing the profound love humans hold for their pets and the significant expenses they incur to keep them healthy, Stemtech has developed StemPets. This natural stemceutical product promises to offer amazing health benefits to pets as our human products have provided for nearly two decades.

“We are thrilled to introduce StemPets to the market,” said Charles S. Arnold”, Chairman & CEO of Stemtech.

He goes on to say that

“pet owners go to great lengths to ensure the well-being of their animals, and StemPets offers a natural solution that supports their health. Our product is not only beneficial for pet health, but is also appealing to them, as animals find the natural flavor pleasant without the need for artificial flavoring. My eight-year-old dog Plato has more energy and vitality since taking StemPets.”

John W. Meyer, President & COO states

“the new StemPets

Read more...

Stemtech Expands Global Reach With New License Agreement In Africa

Stemtech Corporation (OTCQB:STEK), a leading innovator in patented stem cell nutrition health products, announces a significant milestone in its global expansion strategy with the signing of a license Agreement with an established direct sales company, based in Kenya.
The Agreement, effective January 29th, 2024, grants the license to purchase, use, market, and distribute Stemtech’s cutting-edge health related products within the designated Territory(s), including Kenya, Uganda, Tanzania, Ghana, Democratic Republic of Congo and Nigeria.
This strategic move represents Stemtech’s commitment to reaching new markets and introducing its patented stem cell nutrition, skin care and oral care products to new markets. The licensing agreement includes the distribution of StemRelease3™, StemFlo Advanced®, MigraStem™, OraStem™, and Cellect One™ Rapid Renew Stem Cell Peptide Night Cream.
John W. Meyer, President & COO of Stemtech Corporation, expressed excitement about the expansion, stating,

“We believe that this partnership marks a significant opportunity for Stemtech to establish brand recognition in key African markets and contribute to the overall health and wellness of the region.
We are confident that our stem cell nutrition products will make a positive impact and contribute to the growth of the wellness industry in Africa. Distributors will benefit from additional income for the current network marketers already engaged through

Read more...

Stemtech Announces Jeff Weisberg As Director Of New Business Development

Stemtech President and COO, John W. Meyer, comments that “the addition of Jeff Weisberg, with his vast experience in direct sales, having generated approximately a billion dollars in sales over his decades long career, joins us to further expand our growing Field of Stemtech distributors and consumers.
His global experience in this $200 billion-dollar direct sales industry entails coaching, training, motivation and working with some of the most successful companies over the span of his career.
This fits into our Vision 2023 expansion strategy perfectly. Jeff, a serial entrepreneur who has also run his own businesses, in addition to developing others as a consultant, has experience in bringing innovative products to the marketplace that are not sold through traditional retail stores, but that develop distribution through the network marketing model.
His years of experience are not only in the U.S., but globally including Asia, Europe, the Middle East and Latin America. Jeff will complement Stemtech’s existing operations and energize our current Stemtech business partners while adding new leaders as well as new consumers.
Jeff has accomplished and achieved great success and we look forward to working with him”. Meyer goes on to say that “Jeff Weisberg’s first responsibility will be conducting training

Read more...

StemTech Launches In Colombia

President and Chief Operating Officer, John W. Meyer, says:
“Stemtech has started working to launch Stemtech Colombia with our country offices intended to be located in Bogota. During our Leadership Event held last December 2022 in Cancun, Mexico, we were requested by our Field leaders to undertake opening a Colombia office.
Given the existing relationships between our Latin American Independent Business Partners (IBPs) and residents in that country. This also fits into our company concept of ‘Just One More’ by adding a new market”.
Stemtech CEO, Charles S. Arnold, says:
“Colombia is a very exciting market for Stemtech as it is a great country in which to introduce the health and wellness benefits of our anti-aging, all-natural, plant-based stemceutical™ products.
In addition, technology advances we have made with our AdvanceOffice mobile app, will help to provide leading-edge communication and easier recruiting tools for our IBPs to share the Stemtech opportunity for building an entrepreneurial business for Colombian citizens with the opportunity to earn additional income”.
Stemtech`s Vice President of Global Sales, Alejandro Carrillo states:
“the VISION 2023 strategic business plan initiative includes expansion of our Latin American markets. This is the first step toward achieving this objective this year. Colombia is an opportunity as one

Read more...

Stemtech Anticipates Growth Rate In 2023 Will Exceed 2022

Stemtech today announced VISION 2023 concerning the exciting developments planned for the new year.
President and Chief Operating Officer, John W. Meyer says that “VISION 2023 for Stemtech was built on the foundations we enacted over the course of 2022.
“Our efforts were rewarded with a 20% growth of new Independent Business Partners (IBPs) and customers over FY 2021. We anticipate that this growth rate will actually be exceeded this year.
We introduced the powerful AdvanceOffice Mobile app for all of our distributors which enables them to operate their entire business via the app.
We launched a new proprietary blend named “CellectOne™”, a Rapid Renew Stem Cell Peptide Night Cream; we held our international conference in Cancun, Mexico this past December. Each one of these investments have generated exciting growth far beyond our expectations”
“For the upcoming fiscal year, we expect to increase our customer base as well as revenue. Much of this stems not only from our new product lines or increasing sales, but as much our human factor.
Our Field attendees came away from our Cancun event filled with excitement and new strategies to take to their customers, sharing the many opportunities of Stemtech.
We believe that sales will increase considerably in 2023

Read more...

Stemtech Appoints Margie And Mike Mares To The Field Advisory Board

Stemtech today announced the appointment of Margie and Mike Mares of Stemtech Mexico to Stemtech’s Field Advisory Board (FAB).
Stemtech President & Chief Operating Officer, John W. Meyer, says
“it is my distinct pleasure to announce the appointment of the dynamic Independent Business Partner (IBP) team of Margie and Mike Mares to our Field Advisory Board. They are a young, dynamic couple that contributed to our business from the day they joined Stemtech.
Becoming members of our FAB, joining Founding IBP, Network Marketing Hall of Fame Member, Izzy Matos (U.S.), Chairman Claudia Zamudio (Mexico), Chairman Ana Groenewold (Mexico), Triple Diamond Luigi Gonzalez (U.S.) and Sam Holland (U.S.) enables us to continue to work in full transparency and open communication between corporate and our Field in a true partnership.
We listen to one another for the best business ideas to grow our enterprise.”
Alexandro Carrillo, Stemtech Vice President Global Sales, comments that
“during their first month after joining in July 2021, Margie and Mike became Sapphire Directors and within six months, they achieved Diamond Director level. It continues to be a pleasure to work with these two energetic leaders who will continue to propel Stemtech to new heights, sharing our stemceutical™ all-natural, anti-aging, plant based

Read more...

Stemtech Honored By The Taiwan government

Stemtech corporation today announced that Stemtech’s Taiwan Branch was honored by the Taiwan government agency which monitors the MLM businesses in Taiwan.
Stemtech Corporation, Taiwan Branch, was praised by the Multi-Level Marketing Protection Foundation for its long-term, deep cultivation of the MLM industry in Taiwan. During the Multi-Level Marketing industry Summit forum held December 19th, our General Manager-Richard Hu took the stage to accept praise and adulation.
He says
“every year, more than 70 MLM companies are established, but there are also more than 70 disbanded. 90% of the organizations do not survive the first year. Such figures indicate that it is a very rare thing to become a firmly footed networking company in Taiwan. Stemtech has been licensed and operating in Taiwan for 14 years, among hundreds of MLM companies that come and go.
We are standing in the top ten percent position in terms of duration. While operating in this challenging market, it also reflects the high degree of recognition of Stemtech’s products and business opportunity that we have provided to Taiwan for so many years!”
Stemtech Corporation Chief Executive Officer, Charles S. Arnold comments that
“it is quite an honor to be lauded by this prestigious organization in Taiwan. It is a tribute

Read more...

Stemtech Increases Recruitment By 38%

According to a Stemtech press release:
Stemtech Corporation (“Stemtech”) (CQB:OTSTEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, announced today that the Company increased independent business partner recruiting by 38% for the period from April 1, 2022 through June 20, 2022, as compared to the same period last year.
Independent business partners include distributors, customers, wholesale buyers, business builders and VIP Customers.
“We are thrilled about the recent increase in recruitment for Stemtech,”
said Charles Arnold, Chairman and CEO of Stemtech.
“Recruitment is the lifeblood of direct sales companies and we are very encouraged by our results so far in the second quarter of 2022. We intend to continue our outreach and expansion efforts, and build on this momentum going forward.”
Stemtech recently moved up 174 places in the Business For Home Momentum Ranks from the previous year, to achieve a ranking of 93 out of a total of 722 of the top companies in the industry. The results can be seen on the Business For Home web site at www.businessforhome.org.

Stemtech specializes in creating products and formulas that are patent protected in the U.S. and international markets. The Company’s patented formulas help the release, circulation and migration of

Read more...

Ana Groenewold From Mexico Achieves Chairman Rank At Stemtech

Stemtech Corporation (“Stemtech”) (OTCQB:STEK), an innovative nutraceutical company and a pioneer in the field of ADVANCELLS stem cell nutrition, announced today that Ana Groenewold, an Independent Business Partner from Mexico, has attained the high rank of Chairman’s Club Director in May.
This coincided with the GLD RSH 90-Day Promotion period where sales and recruitment reached a record 2022 May.
John W. Meyer, President & COO of Stemtech Corporation says:
“Ana is a very dedicated and determined person who set her sights on becoming a Chairman’s Club Director and excitedly attained this high rank in May.
Stemtech is proud of Ana’s accomplishments and applauds her efforts to share the benefits of our great products and business opportunity.
Chairman & CEO Charles Arnold and I both were very happy to call Ana and congratulate her success. Ana Groenewold has worked with so many, including Stemtech’s Managing Director of Latin Markets, Alejandro Carrillo, who expresses his admiration for Ana’s drive to succeed.”
Ana commented that
“I wanted a project with the potential to change the world! 9 years ago, I found Stemtech and since then the passion was born in me to not stop for a single day! I love Stemtech, I love my life, I love my great,

Read more...

Ana Groenewold Alcanza El Nivel De Chairman En Stemtech

Stemtech Corporation (“Stemtech”) (OTCQB:STEK), una empresa nutracéutica innovadora y pionera en el campo de la nutrición con células madre ADVANCELLS, anunció hoy que Ana Groenewold, socia de negocio independiente de México, ha alcanzado el alto rango de Director del Club del Chairman en mayo.
Esto coincidió con el período de promoción de 90 días de GLD RSH en el que las ventas y el reclutamiento alcanzaron un récord en mayo de 2022.
“Ana es una persona muy dedicada y determinada que se fijó en convertirse en el rango del Club del Chairman y obtuvo con entusiasmo este alto rango en mayo”, dice John W. Meyer, presidente y director de operaciones de Stemtech Corporation.
“Stemtech se enorgullece de los logros de Ana y aplaude sus esfuerzos por compartir los beneficios de nuestros excelentes productos y la oportunidad de negocio”, continuó Meyer.
“El presidente y director ejecutivo Charles Arnold y yo estuvimos muy felices de llamar a Ana y felicitarla por su éxito”, dijo Meyer.
Ana Groenewold ha trabajado con muchos, incluido el Director General de Mercados Latinos de Stemtech, Alejandro Carrillo, quien expresa su admiración por el impulso de Ana para tener éxito.
Ana comentó que
“¡Quería un proyecto con el potencial de cambiar el

Read more...